This technology describes a chemical method for producing the novel sugar alcohol 3,6-anhydro-L-galactitol (L-AHGol) and the disaccharide-form agarobaititol (ABol) from seaweed.
Production pathways for efficiently obtaining high-value sugar alcohols from marine biomass have been limited.
This technology contributes to the production of high-value materials based on marine biomass by utilizing red algae-derived components to produce novel sugar alcohols and disaccharide-form derivatives.
This technology relates to an in vivo applicable hydrogel composition comprising a hydrophilic natural polymer-crosslinking compound and a polyhydric alcohol, and its manufacturing method.
Existing vitreous substitutes, such as expansive gas and silicone oil, had limitations, requiring specific postures or potentially causing toxicity and complications.
This hydrogel features rapid self-curing and a refractive index and transparency similar to the vitreous humor, enabling immediate vision recovery after intraocular injection. It is utilized as a vitreous substitute implant with excellent biocompatibility.
This technology relates to a carbon dioxide sleep induction device that mixes and discharges outside air with carbon dioxide, controlling the flow rate based on distance information to the user's face.
Existing sleep aid devices have struggled to maintain a consistent carbon dioxide concentration because they cannot adapt to changes in the user's position.
To address this, the technology uses distance sensor data to regulate the carbon dioxide flow or outside air intake, inducing sleep with a stable concentration of mixed gas.
This technology provides an automated design method for building exterior panels. It loads architectural drawings to identify building information, cross-references data from exterior panel and fastener databases, and automatically generates design specifications tailored to specific load requirements.
Conventional exterior panel design relies on manual input of load conditions and materials, which is time-consuming and prone to errors.
By integrating architectural drawings with material databases to automate the design process, this technology reduces design time and improves accuracy in building exterior construction.
This technology describes a nano-hybrid catalyst for hydrogen production, featuring alternately stacked layers of facet-controlled 2D platinum nanodendrite sheets and NiFe double-layered hydroxide nanosheets, along with its manufacturing method.
Conventional platinum catalysts have suffered from low efficiency and instability in alkaline hydrogen production.
This technology improves the efficiency and stability of alkaline hydrogen production through an alternately stacked structure of facet-controlled platinum nanodendrites and NiFe double-layered hydroxides.
This technology is a biomolecule detection device that quickly and easily detects multiple disease-related biomolecules to diagnose the presence of disease.
There was a need for a simple device that could quickly and accurately detect multiple biomolecules simultaneously to diagnose diseases.
This technology identifies and detects multiple biomolecules by coating coded microchips, which pass through micropore elements, with sensing molecules that complementarily bind to target biomolecules, and then sensing the chip's code through changes in current inside the pores.
This technology relates to a composition for the prevention and treatment of liver disease, comprising 12-LOX or its expression promoter as an active ingredient, which enhances the effect of docosahexaenoic acid (DHA).
An auxiliary target was needed to fully maximize the beneficial effects of DHA on liver disease.
This technology confirmed that 12-LOX or its expression promoter significantly increases the liver disease improvement, prevention, and treatment effects of DHA, thus allowing it to be utilized as an effective composition for liver disease.
This technology relates to a carbon dioxide sleep induction device that mixes and discharges CO2 with ambient air, controlling the flow rate based on the distance to the user's face.
Existing sleep aids struggle to maintain stable CO2 concentrations because they cannot adapt to changes in the user's posture or distance.
To address this, our technology uses a distance sensor to detect the distance to the face and adjusts the CO2 flow and ambient air intake, safely inducing sleep with an optimal concentration of the gas mixture.
This technology concerns an RNA interference-inducing nucleic acid that inhibits off-target genes of microRNA by modifying a partial sequence of a specific microRNA.
Conventional microRNAs regulate both on-target and off-target genes, which presented a limitation in selectively inducing only desired biological functions.
The interference-inducing nucleic acid of this technology can selectively enhance and induce functions resulting from off-target inhibition, making it applicable in various fields such as pharmaceuticals and cosmetics that regulate cell cycle, differentiation, migration, proliferation, and apoptosis.
This technology involves a transformed Vibrio DHG strain for lignocellulosic biomass processing and a method for producing lactic acid using this strain.
Lignocellulosic biomass has faced limitations in simultaneously metabolizing various sugars and converting them into high-value compounds.
The transformed strain developed with this technology can simultaneously metabolize glucose, xylose, and arabinose to produce lactic acid, making it useful for microbial-based production of high-value compounds.
This technology provides a composition for inducing neuroectodermal differentiation of stem cells, comprising a TGF-β receptor ALK5 inhibitor, a BMP inhibitor, and an MMP inhibitor.
There was a need for a method to efficiently differentiate stem cells into specific cells for cell therapy.
This technology enhances differentiation efficiency by treating human embryonic and induced pluripotent stem cells with three types of inhibitors, which promotes neuroectodermal differentiation.
This technology describes a method for manufacturing low-friction and anti-fouling surfaces with lubricant-containing spherical cavities, biomimicking the mucus secretion structure of marine organisms.
Existing anti-fouling surfaces had limitations, as their performance degraded over time, necessitating frequent repainting of ship hulls.
This technology maintains excellent drag reduction and anti-fouling performance over a long period by retaining liquid lubricant within spherical cavities and preventing its loss. It can also be applied to large-area surfaces.
This technology relates to a method for building a virtual space that corresponds to a physical space and providing online services within partitioned spaces based on the location information of a user terminal.
Existing online services are provided regardless of the user's actual location or space, making it difficult to implement services integrated with physical environments.
To address this, this technology provides services in virtual partitioned spaces that correspond to physical spaces identified by location information, enabling location-based services that are accessible only within specific areas.
This technology relates to an RNA interference-inducing nucleic acid that inhibits off-target genes of microRNA by modifying a partial sequence of a specific microRNA.
Conventional microRNAs regulate both on-target and off-target genes, posing a limitation in selectively inducing only desired biological functions.
The interference-inducing nucleic acid of this technology can selectively enhance and induce functions resulting from off-target inhibition, making it applicable in various fields such as pharmaceuticals and cosmetics that regulate cell cycle, differentiation, migration, proliferation, and apoptosis.
This technology concerns an RNA interference-inducing nucleic acid that inhibits off-target genes of microRNA by modifying a portion of a specific microRNA's sequence.
Conventional microRNAs regulate both on-target and off-target interactions, which presented a limitation in selectively inducing only desired biological functions.
The RNAi-inducing nucleic acid of this technology can selectively enhance and induce functions that arise from off-target inhibition. This allows for its application in diverse fields, including pharmaceuticals and cosmetics, for regulating processes such as cell cycle, differentiation, migration, proliferation, and apoptosis.
